StockData
Olema Oncology, Inc. logo

Olema Oncology, Inc. (OLMA) stock

OLMANasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 8/30
$7.22−0.14 (-1.90%)

Close on Nov 17, 2026Market cap $631.73MP/E –Yield –

Olema Oncology operating cash flow

Operating cash flow is the cash the business generates from its day-to-day operations.

Olema Oncology's operating cash flow for the twelve months ending Jun 30, 2026 was -$164.74M. For fiscal 2025 it was -$146.72M. The highest annual figure on record is -$3.08M in fiscal 2019.

Annual operating cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$146.72M–
FY2024Dec 31, 2024-$104.35M–
FY2023Dec 31, 2023-$83.73M–
FY2022Dec 31, 2022-$82.07M–
FY2021Dec 31, 2021-$50.69M–
FY2020Dec 31, 2020-$19.87M–
FY2019Dec 31, 2019-$3.08M–

Quarterly operating cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$45.90M–
Q1 FY2026Mar 31, 2026-$45.99M–
Q4 FY2025Dec 31, 2025-$38.33M–
Q3 FY2025Sep 30, 2025-$34.53M–
Q2 FY2025Jun 30, 2025-$29.88M–
Q1 FY2025Mar 31, 2025-$43.98M–
Q4 FY2024Dec 31, 2024-$26.28M–
Q3 FY2024Sep 30, 2024-$27.02M–
Q2 FY2024Jun 30, 2024-$27.56M–
Q1 FY2024Mar 31, 2024-$23.50M–
Q4 FY2023Dec 31, 2023-$18.48M–
Q3 FY2023Sep 30, 2023-$22.74M–
Q2 FY2023Jun 30, 2023-$22.12M–
Q1 FY2023Mar 31, 2023-$20.39M–
Q4 FY2022Dec 31, 2022-$19.71M–
Q3 FY2022Sep 30, 2022-$17.99M–
Q2 FY2022Jun 30, 2022-$26.46M–
Q1 FY2022Mar 31, 2022-$17.90M–
Q4 FY2021Dec 31, 2021-$18.60M–
Q3 FY2021Sep 30, 2021-$12.10M–
Q2 FY2021Jun 30, 2021-$8.91M–
Q1 FY2021Mar 31, 2021-$11.08M–
Q4 FY2020Dec 31, 2020-$9.01M–
Q3 FY2020Sep 30, 2020-$7.54M–
Q2 FY2020Jun 30, 2020-$1.18M–
Q1 FY2020Mar 31, 2020-$2.14M–

More Olema Oncology figures

See a number that looks wrong?